↓ Skip to main content

β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
43 Mendeley
Title
β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer
Published in
Breast Cancer Research and Treatment, July 2019
DOI 10.1007/s10549-019-05341-6
Pubmed ID
Authors

Sasagu Kurozumi, Kyoichi Kaira, Hiroshi Matsumoto, Tomoko Hirakata, Takehiko Yokobori, Kenichi Inoue, Jun Horiguchi, Ayaka Katayama, Hiromi Koshi, Akira Shimizu, Tetsunari Oyama, Erica K. Sloan, Masafumi Kurosumi, Takaaki Fujii, Ken Shirabe

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 14%
Student > Postgraduate 5 12%
Student > Doctoral Student 4 9%
Student > Ph. D. Student 4 9%
Student > Master 4 9%
Other 8 19%
Unknown 12 28%
Readers by discipline Count As %
Medicine and Dentistry 11 26%
Biochemistry, Genetics and Molecular Biology 8 19%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Chemistry 2 5%
Social Sciences 1 2%
Other 3 7%
Unknown 15 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2020.
All research outputs
#14,657,483
of 23,923,788 outputs
Outputs from Breast Cancer Research and Treatment
#3,132
of 4,804 outputs
Outputs of similar age
#186,402
of 348,858 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#33
of 68 outputs
Altmetric has tracked 23,923,788 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,804 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,858 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.